Skeletal effects of Oxytocin and Vasopressin
Main Article Content
Over the last decade, the relevance of the pituitary-bone axis has been recognized. Oxytocin (OXT), arginine vasopressin (AVP), growth hormone (GH), follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), adrenocorticotrophic hormone (ACTH) and prolactin have a dominant action on the skeleton as demonstrated by the fact that genetically modified mice lacking their ligands or receptors exhibit a skeletal phenotype, although the primary target organs remain unaltered. Unraveling these new mechanisms of action of the pituitary hormones has paved the way for new therapeutic opportunities in the treatment of osteoporosis. Here, we summarize the action and interaction of OXT and AVP, closely related small peptides that modulate reciprocal secretion and receptor expression on bone cells, in the physiologic context of the skeletal homeostasis.
Authors will be required to fill out the below copyright transfer form during the peer-review process and attach it along with their submission. In return, Knowledge Enterprises Journals grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by Knowledge Enterprises Journals.